Recorded Chinese product: 盐酸丙卡特罗片盐酸丙卡特罗片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 安徽环球药业股份有限公司Chinese legal name: 安徽环球药业股份有限公司
主要成分Active Ingredients
- 丙卡特罗Bingka Teluo
药物知识说明
丙卡特罗是一种在国家药监局注册认定的药品。该药品含有丙卡特罗-938b0bc5等成分。
该药品关联的活性成分包括：丙卡特罗Bingka Teluo。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：安徽环球药业股份有限公司Chinese legal name: 安徽环球药业股份有限公司。
您可以探索含有相同成分的其他药品：丙卡特罗-938b0bc5成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸丙卡特罗片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 丙卡特罗Bingka Teluo.
Manufacturers recorded for this product: 安徽环球药业股份有限公司Chinese legal name: 安徽环球药业股份有限公司.
Explore other medicines containing the same ingredient: 丙卡特罗 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸丙卡特罗片Recorded Chinese product: 盐酸丙卡特罗片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 25μg*40片25 μg × 40 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 安徽环球药业股份有限公司Chinese legal name: 安徽环球药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H34023109
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H34023109
Manufacturer
Chinese legal name: 安徽环球药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
25 μg × 40 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H34023109
生产企业
安徽环球药业股份有限公司(国产)
适应症
本品为支气管扩张剂。适用于支气管哮喘、喘息性支气管炎、伴有支气管反应性增高的急性支气管炎、慢性阻塞性肺部疾病。
用法用量
口服： 1.成人：一次50μg(2片)，一日1次,睡前服用或一次50μg(2片)，一日2次，清晨及睡前服用。 2.6岁以上儿童：一次25μg(1片)，服用方法同成人，儿童可依据年龄、症状和体温适当增减。
不良反应
1.偶有口干、鼻塞、倦怠、恶心、胃部不适、肌颤、头痛、眩晕或耳鸣。
2.亦可发生皮疹、心律失常、心悸、面部潮红等。
禁忌
对本品及肾上腺素受体激动药过敏者禁用。
注意事项
1.有可能引起心律失常，服用时应予注意。
2.以下患者慎服：甲状腺机能亢进、高血压、心脏病、糖尿病。
3.妊娠期服用本药的安全性尚未确立，所以对孕妇或有可能妊娠的妇女应权衡利弊方可服用。
4.早产儿、新生儿、乳儿和幼儿服用的安全性尚未确立，慎用。
5.老年患者应慎用或遵医嘱。
贮藏
遮光，密封保存。
规格
25μg*40片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.